Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective was to investigate the influence of 2 different dosage regimens (5 mg once daily vs. 2.5 mg twice daily) on the steady-state pharmacokinetics and pharmacodynamics of orally administered BI 1356.
Epistemonikos ID: bf113a62436f0972bc40ff7c6f1b735712ba35ef
First added on: May 11, 2024